Financials
- Market Capitalization 2.19 B
- Employee 128
- Founded 2012
- CEO N/A
- Website www.auriniapharma.com
- Headquarter Alberta, Canada
- FIGI BBG000BCRJM5
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1927 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 21.59 USD | +10.95% | +11.35% | +39.92% | +17.98% | 2.28 B USD | ||
| 1937 | URGN UroGen Pharma Ltd. - Ordinary Shares | 45.50 USD | -0.96% | -2.94% | +10.71% | +139.47% | 2.22 B USD | ||
| 1953 | NBTX Nanobiotix S.A. - ADSs | 45.16 USD | +1.48% | +2.78% | +20.36% | +385.59% | 2.19 B USD | ||
| 1958 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 8.37 USD | -5.96% | +1.09% | +22.55% | +251.68% | 2.17 B USD |
Frequently asked questions about Aurinia Pharmaceuticals Inc
What is the Aurinia Pharmaceuticals Inc stock price today?
The current price of Aurinia Pharmaceuticals Inc (AUPH) is 16.48. Over the past 24 hours, the stock has changed by -0.36%. Follow the AUPH chart for real-time price dynamics.
What is the stock ticker of Aurinia Pharmaceuticals Inc?
Aurinia Pharmaceuticals Inc trades under the ticker AUPH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Aurinia Pharmaceuticals Inc stock going up?
AUPH has changed by -4.19% over the last week, +10.23% over the last month, and +38.14% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Aurinia Pharmaceuticals Inc?
Aurinia Pharmaceuticals Inc currently has a market capitalization of 2.19 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Aurinia Pharmaceuticals Inc earnings last quarter?
Last quarter, Aurinia Pharmaceuticals Inc reported earnings of 0.29 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Aurinia Pharmaceuticals Inc revenue for the last quarter?
Aurinia Pharmaceuticals Inc reported quarterly revenue of 83.22 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Aurinia Pharmaceuticals Inc net income for the last quarter?
Aurinia Pharmaceuticals Inc reported net income of 37.41 M for the last quarter. The previous quarter showed 34.35 M, which means net income changed by +8.90%.
How many employees does Aurinia Pharmaceuticals Inc have?
As of the latest available data, Aurinia Pharmaceuticals Inc has 128 employees. Workforce size can provide additional context about the company's scale and operations.
What is Aurinia Pharmaceuticals Inc EBITDA?
Aurinia Pharmaceuticals Inc EBITDA is 51.17 M, and its EBITDA margin is 61.49%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Aurinia Pharmaceuticals Inc stock?
You can buy Aurinia Pharmaceuticals Inc (AUPH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Aurinia Pharmaceuticals Inc stock?
Investing in Aurinia Pharmaceuticals Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AUPH chart and related analysis on metatrader.com as part of your research.